Evan M Hersh

  • 19105 Citations
  • 67 h-Index
1965 …2021
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Evan M Hersh is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 12 Similar Profiles
Melanoma Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Mycobacterium bovis Medicine & Life Sciences
Lymphocytes Medicine & Life Sciences
Immunotherapy Medicine & Life Sciences
Lymphocyte Activation Medicine & Life Sciences
Leukemia Medicine & Life Sciences
Delayed Hypersensitivity Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 1978 2021

CANCER CENTER SUPPORT GRANT

Davis, T. P., Hersh, E. M., Weinstein, R. S., Miesfeld, R., Miller, T. P., Tsaprailis, G., Lynch, R., Chow, H., Nagle, R. B., Watts, G. S., Thomson, C., Roe, D., Stratton, S. P., Alberts, D. S., Hurley, L., Baker, A. F., Livingston, R. B., Dorr, R. T., Cress, A. E., Briehl, M. M., Mash, E. A., Duffy, J., Jones, S., Leibovitz, A., Meyskens, F., Moon, T., Trent, J., Newkirk, D., Von Hoff, D., Mount, D., Doetschman, T., Liebler, D., Marshall, J., McGovern, K., Grogan, T., Kraft, A., Powis, G., Peng, Y., Gerner, E., Aickin, M., Ritenbaugh, C., Taylor, C., Powell, M. B., Bowden, T., Taetle, R., Salmon, S., Ignatenko, N., Bhattacharyya, A. K., Futscher, B. W., Barton, J. K., Montfort, W. "., Roe, D., Garland, L. L., Doetschman, T. C., Kraft, A., Chow, H. & Ellis, N.

National Institutes of Health

9/1/786/30/21

Project: Research project

Neoplasms
Research
Pharmaceutical Services
Research Personnel
Clinical Trials

CLINICAL ONCOLOGY RESEARCH TRAINING

Hersh, E. M. & Taetle, R.

National Institutes of Health

9/24/928/31/98

Project: Research project

Medical Oncology
Research
Education
Neoplasms
Physicians
Monoclonal Antibodies
HIV
HIV Antibodies
Antibody-Dependent Cell Cytotoxicity
Epitopes

DRUG DISCOVERY GROUP FOR THE TREATMENT OF AIDS

Hersh, E. M., Shannon, W., Stephens, E. B. & Chirigos, M.

National Institutes of Health

9/30/879/30/94

Project: Research project

Drug Discovery
Biomedical Research
Acquired Immunodeficiency Syndrome
Preclinical Drug Evaluations
Immunologic Factors
Kaposi's Sarcoma
AIDS-Related Complex
Acquired Immunodeficiency Syndrome
Blood Banks
Blood Donors

Research Output 1965 2017

  • 19105 Citations
  • 67 h-Index
  • 490 Article
  • 48 Chapter
  • 3 Letter
  • 1 Conference contribution
19 Citations (Scopus)

Long-Term Survival after Complete Surgical Resection and Adjuvant Immunotherapy for Distant Melanoma Metastases

MMAIT-IV Clinical Trial Group, Dec 1 2017, In : Annals of Surgical Oncology. 24, 13, p. 3991-4000 10 p.

Research output: Contribution to journalArticle

Mycobacterium bovis
Immunotherapy
Melanoma
Neoplasm Metastasis
Survival
2 Citations (Scopus)

A Phase 2 Randomized, Double-Blind, Multicenter Trial of Imexon Plus Gemcitabine Versus Gemcitabine Plus Placebo in Patients With Metastatic Chemotherapy-naïve Pancreatic Adenocarcinoma

Cohen, S. J., Zalupski, M. M., Conkling, P., Nugent, F., Ma, W. W., Modiano, M., Pascual, R., Lee, F. C., Wong, L. & Hersh, E. M., Dec 24 2015, (Accepted/In press) In : American Journal of Clinical Oncology: Cancer Clinical Trials.

Research output: Contribution to journalArticle

gemcitabine
Multicenter Studies
Adenocarcinoma
Placebos
Drug Therapy
22 Citations (Scopus)

A randomized, controlled phase III trial of nab-Paclitaxel versus dacarbazine in chemotherapy-naïve patients with metastatic melanoma

Hersh, E. M., Del Vecchio, M., Brown, M. P., Kefford, R., Loquai, C., Testori, A., Bhatia, S., Gutzmer, R., Conry, R., Haydon, A., Robert, C., Ernst, S., Homsi, J., Grob, J. J., Kendra, K., Agarwala, S. S., Li, M., Clawson, A., Brachmann, C., Karnoub, M. & 3 others, Elias, I., Renschler, M. F. & Hauschild, A., Nov 1 2015, In : Annals of Oncology. 26, 11, p. 2267-2274 8 p., mdv324.

Research output: Contribution to journalArticle

Dacarbazine
Melanoma
Drug Therapy
Disease-Free Survival
Confidence Intervals
8 Citations (Scopus)
Melanoma
Drug Therapy
Investigational Therapies
Immunosuppressive Agents
Therapeutics
208 Citations (Scopus)

A phase II multicenter study of ipilimumab with or without dacarbazine in chemotherapy-naïve patients with advanced melanoma

Hersh, E. M., O'Day, S. J., Powderly, J., Khan, K. D., Pavlick, A. C., Cranmer, L. D., Samlowski, W. E., Nichol, G. M., Yellin, M. J. & Weber, J. S., Jun 2011, In : Investigational New Drugs. 29, 3, p. 489-498 10 p.

Research output: Contribution to journalArticle

Dacarbazine
Multicenter Studies
Melanoma
Drug Therapy
ipilimumab